Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$41.33 - $74.26 $144,200 - $259,093
3,489 Added 6.74%
55,250 $2.33 Million
Q1 2024

May 14, 2024

BUY
$56.27 - $73.77 $920,127 - $1.21 Million
16,352 Added 46.18%
51,761 $3.57 Million
Q4 2023

Feb 13, 2024

BUY
$59.06 - $75.72 $2.09 Million - $2.68 Million
35,409 New
35,409 $2.62 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.2B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Apg Asset Management Us Inc. Portfolio

Follow Apg Asset Management Us Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Apg Asset Management Us Inc., based on Form 13F filings with the SEC.

News

Stay updated on Apg Asset Management Us Inc. with notifications on news.